BlackRock »

Adma Biologics shares owned by BlackRock

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $765M 38M 19.99

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Adma Biologics

BlackRock
BlackRock
Vanguard Group
Invesco
Nuveen Asset Management
State Street Corporation
Geode Capital Management
D. E. Shaw & Co
Two Sigma Advisers
Morgan Stanley
AWM Investment Company
American Century Companies
Deutsche Bank Aktiengesellschaft
Two Sigma Investments
Dimensional Fund Advisors

View all funds holding Adma Biologics